Lisdexamfetamine

Trade Name: 
Vyvanse
Manufacturer/Distributor: 
Shire; Medical Information 1-800-268-2772
www.shire.com
Classification: 
CNS stimulant
ATC Class: 
N06BA Centrally acting sympathomimetics
Status: 
active
Notice of Compliance (yyyy/mm/dd): 
2009/02/19
Date Marketed in Canada (yyyy/mm/dd): 
2010/04/20
Presentation: 
capsule 20 mg; DIN 02347156
capsule 30 mg; DIN 02322951
capsule 40 mg; DIN 02347164
capsule 50 mg; DIN 02322978
capsule 60 mg; DIN 02347172
Comments: 
For treatment of attention deficit hyperactivity disorder in children aged 6 to 12 years.
Source: 
Letter from company.